Allopurinol as therapy for dilated cardiomyopathy in a transgenic mouse model of myocardial stunning

被引:0
|
作者
Duncan, JG [1 ]
Stull, LB [1 ]
Murphy, AM [1 ]
机构
[1] Johns Hopkins Univ, ACCM, Baltimore, MD USA
关键词
D O I
10.1097/00003246-200212001-00006
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
6
引用
收藏
页码:A2 / A2
页数:1
相关论文
共 50 条
  • [21] Therapeutic effects of celecoxib on the mouse model of dilated cardiomyopathy
    Fan, Xue-Li
    Takahashi, Fumi
    Zhan, Dong-Yun
    Morimoto, Sachio
    Sasaguri, Toshiyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 73P - 73P
  • [22] Myocardial Recovery in Dilated Cardiomyopathy with Goal Directed Medical Therapy
    McCants, Kelly C.
    Alkhalil, Bassil Bassil
    Gardner, Cynthia
    Newhouse, Dana Dana
    Vessels, Kimberly Kimberly
    Kennedy, John
    Del Busto, Sara
    Vongooru, Haree
    Ghotra, Amaninderapal S.
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S91 - S91
  • [23] Targeted overexpression of Bcl-2 prevents left ventricular remodeling in a transgenic mouse model of dilated cardiomyopathy
    Haudek, SB
    Nemoto, S
    Engel, D
    Schneider, MD
    Mann, DL
    CIRCULATION, 2002, 106 (19) : 161 - 161
  • [24] Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy
    Aminzadeh, Mohammad A.
    Tseliou, Eleni
    Sun, Baiming
    Cheng, Ke
    Malliaras, Konstantinos
    Makkar, Raj R.
    Marban, Eduardo
    EUROPEAN HEART JOURNAL, 2015, 36 (12) : 751 - 762
  • [25] Angiotensin converting enzyme inhibitors in the treatment of cTnTR141W transgenic mouse model of dilated cardiomyopathy
    Li, Qianxiao
    Yu, Qin
    Na, Rongmei
    Liu, Baiting
    Li, Qianxiao
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (11): : 4752 - 4755
  • [26] Functional investigation of a transgenic mouse model of dilated cardiomyopathy with the Glu361Gly mutation in cardiac actin
    Dyer, Emma
    Wells, Dominic
    Redwood, Charles
    Marston, Steven
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 40 (06) : 941 - 941
  • [27] Steroid treatment causes deterioration of myocardial function in the δ-sarcoglycan-deficient mouse model for dilated cardiomyopathy
    Bauer, R.
    MacGowan, G. A.
    Blain, A.
    Bushby, K.
    Straub, V.
    CARDIOVASCULAR RESEARCH, 2008, 79 (04) : 652 - 661
  • [28] MYOCARDIAL ENERGETICS IN DILATED CARDIOMYOPATHY
    THIERFELDER, L
    HOLUBARSCH, C
    HASENFUSS, G
    JUST, HJ
    CLINICAL CARDIOLOGY, 1990, 13 (09) : 649 - 654
  • [29] Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy
    Lim, DS
    Lutucuta, S
    Bachireddy, P
    Youker, K
    Evans, A
    Entman, M
    Roberts, R
    Marian, AJ
    CIRCULATION, 2001, 103 (06) : 789 - 791
  • [30] THERAPY OF DILATED CARDIOMYOPATHY
    HESS, OM
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 111 (06) : 222 - 225